Document is current
Any future updates will be listed below
-
Authors
Naifeh, James A. https://orcid.org/0000-0001-7248-3054
Edwards, Emily R.
Bentley, Kate H.
Gildea, Sarah M.
Kennedy, Chris J.
King, Andrew J.
Kleiman, Evan M.
Luedtke, Alex
Nassif, Thomas H.
Nock, Matthew K.
Sampson, Nancy A.
Zainal, Nur Hani
Stein, Murray B.
Capaldi, Vincent F.
Ursano, Robert J.
Kessler, Ronald C. https://orcid.org/0000-0003-4831-2305
-
Funding
Funding for this research was provided by:
United States Department of Veterans Affairs, Clinical Sciences Research and Development Service (CSR&D) VA-STARRS Researcher-in-Residence Program
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (U01MH087981, U01MH087981, U01MH087981)
U.S. Department of Defense (HU0001-15-2-0004, HU0001-15-2-0004, HU0001-15-2-0004)
- License Information
-
More Information
Article History
Received: 6 June 2024
Accepted: 18 October 2024
First Online: 6 January 2025
Competing interests
: In the past 3 years, R.C.K. was a consultant for Cambridge Health Alliance, Canandaigua VA Medical Center, Child Mind Institute, Holmusk, Massachusetts General Hospital, Partners Healthcare, Inc., RallyPoint Networks, Inc., Sage Therapeutics and the University of North Carolina. He has stock options in Cerebral Inc., Mirah, Prepare Your Mind, Roga Sciences and Verisense Health. In the past 3 years M.B.S. received consulting income from Actelion, Acadia Pharmaceuticals, Aptinyx, atai Life Sciences, Boehringer Ingelheim, Bionomics, BioXcel Therapeutics, Clexio, EmpowerPharm, Engrail Therapeutics, GW Pharmaceuticals, Janssen, Jazz Pharmaceuticals and Roche/Genentech. M.B.S. has stock options in Oxeia Biopharmaceuticals and EpiVario. He is paid for his editorial work on Depression and Anxiety (Editor-in-Chief), Biological Psychiatry (Deputy Editor) and UpToDate (Co-Editor-in-Chief for Psychiatry). The other authors declare no competing interests.
